Stay updated on Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows a revision label: v3.3.2 replacing v3.3.1 in the site footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T18:13:59.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Branding for the Moffitt Cancer Center Clinical Trials website and a 'Helpful Links Provided by' section were added, and the revision label updated from v3.2.0 to v3.3.1.
    Difference
    0.2%
    Check dated 2025-11-24T15:00:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the site-wide government funding/operating status notice from the page.
    Difference
    0.4%
    Check dated 2025-11-17T07:33:33.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study record for NCT03514017 shows updated details such as the last update date (now 2025-09-22) and associated study dates, including enrollment and results posting timeline.
    Difference
    0.4%
    Check dated 2025-11-03T01:30:29.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Major update to version (v3.2.0) and a government-operating-status notice; removal of a specific resource topic (B-cell chronic lymphocytic leukemia).
    Difference
    6%
    Check dated 2025-10-05T13:22:31.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Updates modernize and expand page metadata to reflect a newer version (v3.1.0) and recent dates (September 2025), while removing older metadata (May 2025, v3.0.2).
    Difference
    1%
    Check dated 2025-09-28T09:28:28.000Z thumbnail image

Stay in the know with updates to Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.